Literature DB >> 19016863

Marine toxins and the cytoskeleton: okadaic acid and dinophysistoxins.

Carmen Vale1, Luis M Botana.   

Abstract

Okadaic acid (OA) and its analogs, the dinophysistoxins, are potent inhibitors of protein phosphatases 1 and 2A. This action is well known to cause diarrhea and gastrointestinal symptons when the toxins reach the digestive tract by ingestion of mollusks. A less well-known effect of these group of toxins is their effect in the cytoskeleton. OA has been shown to stimulate cell motility, loss of stabilization of focal adhesions and a consequent loss of cytoskeletal organization due to an alteration in the tyrosine-phosphorylated state of the focal adhesion kinases and paxillin. OA causes cell rounding and loss of barrier properties through mechanisms that probably involve disruption of filamentous actin (F-actin) and/or hyperphosphorylation and activation of kinases that stimulate tight junction disassembly. Neither methyl okadaate (a weak phosphatase inhibitor) nor OA modify the total amount of F-actin, but both toxins cause similar changes in the F-actin cytoskeleton, with strong retraction and rounding, and in many cases cell detachment. OA and dinophysistoxin-1 (35S-methylokadaic acid) cause rapid changes in the structural organization of intermediate filaments, followed by a loss of microtubules, solubilization of intermediate filament proteins, and disruption of desmosomes. The detailed pathways that coordinate all these effects are not yet known.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016863     DOI: 10.1111/j.1742-4658.2008.06711.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  20 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

Review 2.  Intermediate filaments: primary determinants of cell architecture and plasticity.

Authors:  Harald Herrmann; Sergei V Strelkov; Peter Burkhard; Ueli Aebi
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 3.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

Review 4.  Impact of marine drugs on cytoskeleton-mediated reproductive events.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2010-03-25       Impact factor: 5.118

Review 5.  Targets and effects of yessotoxin, okadaic acid and palytoxin: a differential review.

Authors:  Antonella Franchini; Davide Malagoli; Enzo Ottaviani
Journal:  Mar Drugs       Date:  2010-03-16       Impact factor: 5.118

6.  GENE EXPRESSION PROFILING OF HUMAN LIVER CARCINOMA (HepG2) CELLS EXPOSED TO THE MARINE TOXIN OKADAIC ACID.

Authors:  Lynne A Fieber; Justin B Greer; Fujiang Guo; Douglas C Crawford; Kathleen S Rein
Journal:  Toxicol Environ Chem       Date:  2012-10-10       Impact factor: 1.437

7.  Okadaic Acid Exposure Induced Neural Tube Defects in Chicken (Gallus gallus) Embryos.

Authors:  Yuhu Jiao; Guang Wang; Dawei Li; Hongye Li; Jiesheng Liu; Xuesong Yang; Weidong Yang
Journal:  Mar Drugs       Date:  2021-06-02       Impact factor: 5.118

8.  Effect of okadaic acid on cultured clam heart cells: involvement of MAPkinase pathways.

Authors:  Houda Hanana; Hélène Talarmin; Jean-Pierre Pennec; Mickael Droguet; Julie Morel; Germaine Dorange
Journal:  Biol Open       Date:  2012-09-25       Impact factor: 2.422

Review 9.  Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?

Authors:  Rex Munday
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

10.  Identification of dynamic changes in proteins associated with the cellular cytoskeleton after exposure to okadaic acid.

Authors:  Jill A Opsahl; Sonja Ljostveit; Therese Solstad; Kristin Risa; Peter Roepstorff; Kari E Fladmark
Journal:  Mar Drugs       Date:  2013-05-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.